Alyeska Investment Group
INBS icon

Alyeska Investment Group’s Intelligent Bio Solutions INBS Stock Holding History

Alyeska Investment Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,956
Closed -$127K – 726
2026
Q1 		$127K Buy
+37,956
New +$262K ﹤0.01% 601
2025
Q4 		– Sell
-67,349
Closed -$687K – 656
2025
Q3 		$687K Buy
67,349
+5,960
+10% +$96.1K ﹤0.01% 549
2025
Q2 		$1.06M Hold
61,389
– – ﹤0.01% 504
2025
Q1 		$884K Buy
+61,389
New +$1.15M ﹤0.01% 448
2024
Q4 		– Sell
-20,620
Closed -$357K – 607
2024
Q3 		$357K Buy
+20,620
New +$321K ﹤0.01% 495
2024
Q2 		– Sell
-20,620
Closed -$527K – 618
2024
Q1 		$864K Buy
+20,620
New +$854K 0.01% 419

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Alyeska Investment Group's INBS Position: Q2 2026 in Review

Alyeska Investment Group sold out of Intelligent Bio Solutions (INBS) in Q2 2026, closing a stake of 37,956 shares — an estimated $127K sold.

Alyeska Investment Group first reported a position in INBS in Q1 2024 and held it in 6 quarters. The position peaked at $1.06M in Q2 2025. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Alyeska Investment Group reported no remaining Intelligent Bio Solutions position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 37,956 Intelligent Bio Solutions shares in Q2 2026, an estimated $127K.
  • Alyeska Investment Group first reported a position in Intelligent Bio Solutions in Q1 2024 and held it in 6 quarters.
  • Alyeska Investment Group's Intelligent Bio Solutions position peaked at $1.06M in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.